Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Dec;137(4):445-448.
doi: 10.1016/j.ymgme.2021.03.008. Epub 2021 Mar 13.

Clinical and biochemical footprints of inherited metabolic disease. V. Cerebral palsy phenotypes

Affiliations
Review

Clinical and biochemical footprints of inherited metabolic disease. V. Cerebral palsy phenotypes

Gabriella A Horvath et al. Mol Genet Metab. 2022 Dec.

Abstract

Cerebral palsy is the most common physical disability of childhood describing a heterogeneous group of neurodevelopmental disorders that cause activity limitation, but often are accompanied by disturbances of sensation, perception, cognition, communication and behavior, or by epilepsy. Inborn errors of metabolism have been reported in the literature as presenting with features of cerebral palsy. We reviewed and updated the list of metabolic disorders known to be associated with symptoms suggestive of cerebral palsy and found more than 150 relevant IEMs. This represents the fifth of a series of articles attempting to create and maintain a comprehensive list of clinical and metabolic differential diagnosis according to system involvement.

Keywords: Ataxia; Cerebral palsy; Developmental delay; Developmental regression; Extrapyramidal movement disorder; Hypertonia; Inborn errors of metabolism; Motor developmental delay; Spasticity.

PubMed Disclaimer

Conflict of interest statement

Disclosures

N.B. has nothing to disclose and no conflicts of interest.

G.H. has nothing to disclose and no conflicts of interest.

C.F. has nothing to disclose and no conflicts of interest.

Figures

Figure 1.
Figure 1.
Occurrence (%) of spasticity, extrapyramidal signs or ataxia in a combination with developmental delay or impairment or regression in 13 categories of IEMs. The percentages for neurological involvement were calculated using as the denominator the total number of IEMs in each category presenting with spasticity, extrapyramidal signs or ataxia. Heat scale ranges from red (0%) for diseases with no particular symptoms reported to violet (100%) for diseases with particular symptoms occurring with highly frequency. For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.

References

    1. Ferreira CR, Hoffmann GF, Blau N, Clinical and biochemical footprints of inherited metabolic diseases. I. Movement disorders. Mol Genet Metab 127 (2019) 28–30. - PMC - PubMed
    1. Ferreira CR, Cassiman D, Blau N, Clinical and biochemical footprints of inherited metabolic diseases. II. Metabolic liver diseases. Mol Genet Metab 127 (2019) 117–121. - PMC - PubMed
    1. Horvath GA, Stowe RM, Ferreira CR, Blau N, Clinical and biochemical footprints of inherited metabolic diseases. III. Psychiatric presentations. Mol Genet Metab 130 (2020) 1–6. - PMC - PubMed
    1. Ferreira CR, Blau N, Clinical and biochemical footprints of inherited metabolic diseases. IV. Metabolic cardiovascular disease. Mol Genet Metab (2020). - PMC - PubMed
    1. Lee JJY, Wasserman WW, Hoffmann GF, van Karnebeek CDM, Blau N, Knowledge base and mini-expert platform for the diagnosis of inborn errors of metabolism. Genet Med 20 (2018) 151–158. - PMC - PubMed

MeSH terms